Neopharm's Atonyl to enter the Southeast Asian market.

Published: 2005-09-21 06:59:00

Updated: 2005-09-21 06:59:00

Neopharm Inc. (www.neopharm.co.kr) said that Atonil, an anti-atopic dermatitis drug, would be exported to Taiwan from Oct. this year under the distribution agreement with Youngshin Pharm. co., an affiliate company of YSP group, one of the largest Taiwanese pharmaceutical business groups.

The f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK